Forum of International Respiratory Societies. The Global Impact of Respiratory Disease. Second Edition., https://static.physoc.org/app/uploads/2019/04/22192917/The_Global_Impact_of_Respiratory_Disease.pdf.
Practical Approach to Lung Health: Manual on Initiating PAL Implementation. Geneva: World Health Organization; 2008. 2, Estimating the burden of respiratory diseases., https://www.ncbi.nlm.nih.gov/books/NBK310631/.
Cappa, V. et al. Health-related quality of life varies in different respiratory disorders: a multi-case control population based study. BMC pulmonary Med. 19, 32. https://doi.org/10.1186/s12890-019-0796-8 (2019).
Google Scholar
Figueiredo, D., Gabriel, R., Jácome, C., Cruz, J. & Marques, A. Caring for relatives with chronic obstructive pulmonary disease: how does the disease severity impact on family carers?. Aging Ment. health 18, 385–393, https://doi.org/10.1080/13607863.2013.837146 (2014).
Google Scholar
Majellano, E. C., Clark, V. L., Foster, J. M., Gibson, P. G. & McDonald, V. M. “It’s like being on a roller coaster”: the burden of caring for people with severe asthma. ERJ open. Res. 7, 00812–02020, https://doi.org/10.1183/23120541.00812-2020 (2021).
Google Scholar
Björnsdóttir, U. S., Gizurarson, S. & Sabale, U. Potential negative consequences of non-consented switch of inhaled medications and devices in asthma patients. Int. J. Clin. Pract. 67, 904–910, https://doi.org/10.1111/ijcp.12202 (2013).
Google Scholar
Asthma, G. I. f. Global Strategy for Asthma Management and Prevention, https://ginasthma.org/reports/ (2023).
Barnes, P. J. Inhaled Corticosteroids. Pharmaceuticals 3, 514–540, https://doi.org/10.3390/ph3030514 (2010).
Google Scholar
Lee, H. W., Park, J., Jo, J., Jang, E. J. & Lee, C. H. Comparisons of exacerbations and mortality among regular inhaled therapies for patients with stable chronic obstructive pulmonary disease: Systematic review and Bayesian network meta-analysis. PLoS Med. 16, e1002958, https://doi.org/10.1371/journal.pmed.1002958 (2019).
Google Scholar
Lavorini, F., Janson, C., Braido, F., Stratelis, G. & Løkke, A. What to consider before prescribing inhaled medications: a pragmatic approach for evaluating the current inhaler landscape. Therapeutic Adv. respiratory Dis. 13, 1753466619884532. https://doi.org/10.1177/1753466619884532 (2019).
Google Scholar
Kaplan, A. & van Boven, J. F. M. Switching inhalers: a practical approach to keep on UR RADAR. Pulmonary Ther. 6, 381–392, https://doi.org/10.1007/s41030-020-00133-6 (2020).
Google Scholar
Usmani, O. S. et al. The impact of inhaler device regimen in patients with asthma or COPD. J. Allergy Clin. Immunology: Pract. 9, 3033–3040.e3031, https://doi.org/10.1016/j.jaip.2021.04.024 (2021).
Google Scholar
NICE. NICE guideline [NG115]. Chronic obstructive pulmonary disease in over 16s: diagnosis and management. Published: 05 December 2018 Last updated: 26 July 2019, https://www.nice.org.uk/guidance/ng115/resources/chronic-obstructive-pulmonary-disease-in-over-16s-diagnosis-and-management-pdf-66141600098245.
NICE. NICE guideline [NG80]. Asthma: diagnosis, monitoring and chronic asthma management. Published: 29 November 2017 Last updated: 22 March 2021, https://www.nice.org.uk/guidance/ng80/resources/asthma-diagnosis-monitoring-and-chronic-asthma-management-pdf-1837687975621.
EUR-Lex. Document 52022PC0150. Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on fluorinated greenhouse gases, amending Directive (EU) 2019/1937 and repealing Regulation (EU) No 517/2014., https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A52022PC0150.
GOV.UK. Policy paper. Assessment of the F gas Regulation in Great Britain. A report on the effects of Regulation 517/2014 on fluorinated greenhouse gases (F gases) in Great Britain., https://www.gov.uk/government/publications/assessment-of-the-f-gas-regulation-in-great-britain (Published 16 December 2022.).
Scherpenzeel, A. & te Paske, R. Veel medicatiewissels bij longziekte: ervaringen van patiënten. (Utrecht: Nivel, 2023).
Ninane, V. et al. Usage of inhalation devices in asthma and chronic obstructive pulmonary disease: a Delphi consensus statement. Expert. Opin. drug. delivery 11, 313–323, https://doi.org/10.1517/17425247.2014.872626 (2014).
Google Scholar
Williams, A. E. & Chrystyn, H. Survey of pharmacists’ attitudes towards interchangeable use of dry powder inhalers. Pharm. world Sci. 29, 221–227, https://doi.org/10.1007/s11096-006-9079-6 (2007).
Google Scholar
Usmani, O. S. & Levy, M. L. Effective respiratory management of asthma and COPD and the environmental impacts of inhalers. NPJ Prim. care respiratory Med. 33, 24. https://doi.org/10.1038/s41533-023-00346-7 (2023).
Google Scholar
Price, D. Do healthcare professionals think that dry powder inhalers can be used interchangeably? International journal of clinical practice. Supplement, 26-29 (2005). https://doi.org/10.1111/j.1368-504X.2005.00724.x.
Booker, R. Do patients think that dry powder inhalers can be used interchangeably? International journal of clinical practice. Supplement, 30-32 (2005). https://doi.org/10.1111/j.1368-504X.2005.00725.x.
Lavorini, F. et al. Switching from branded to generic inhaled medications: potential impact on asthma and COPD. Expert. Opin. drug. delivery 10, 1597–1602, https://doi.org/10.1517/17425247.2013.852182 (2013).
Google Scholar
Dekhuijzen, R., Lavorini, F., Usmani, O. S. & van Boven, J. F. M. Addressing the impact and unmet needs of nonadherence in asthma and chronic obstructive pulmonary disease: where do we go from here?. J. allergy Clin. immunology 6, 785–793, https://doi.org/10.1016/j.jaip.2017.11.027 (2018).
Google Scholar
Usmani, O. S. et al. Real-World impact of nonclinical inhaler regimen switches on asthma or COPD: a systematic review. J. Allergy Clin. Immunology: Pract. 10, 2624–2637, https://doi.org/10.1016/j.jaip.2022.05.039 (2022).
Google Scholar
Usmani, O. S. et al. Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respiratory Res. 19, 10. https://doi.org/10.1186/s12931-017-0710-y (2018).
Google Scholar
Humphrey-Murto, S., Varpio, L., Gonsalves, C. & Wood, T. J. Using consensus group methods such as Delphi and Nominal Group in medical education research. Med. Teach. 39, 14–19, https://doi.org/10.1080/0142159x.2017.1245856 (2017).
Google Scholar
Centre for Disease Control and Prevention. Gaining Consensus Among Stakeholders Through the Nominal Group Technique. https://www.cdc.gov/healthyyouth/evaluation/index.htm (Last updated: September 1 2015.).
Varga-Atkins, T., Bunyan, N., Fewtrell, R., McIsaac, J. The Nominal Group Technique – a practical guide for facilitators, https://www.liverpool.ac.uk/media/livacuk/cll/eddev-files/iteach/pdf/guide_for_ELESIG_v1.pdf (2011).
Robinson P., F. Y., Wind C. W. Industrial buying and creative marketing. Vol. ASIN B0006BRX3A (Allyn & Bacon, 1967).
Bourbeau, J. et al. 2023 Canadian Thoracic Society Guideline on Pharmacotherapy in Patients With Stable COPD. Chest 164, 1159–1183, https://doi.org/10.1016/j.chest.2023.08.014 (2023).
Google Scholar
Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. https://goldcopd.org.
NICE. Asthma inhalers Clim. change https://www.nice.org.uk/guidance/ng80/resources/inhalers-for-asthma-patient-decision-aid-pdf-6727144573 (2022).
Global Initiative for Asthma. Global strategy for asthma management and prevention, https://ginasthma.org/wp-content/uploads/2024/05/GINA-2024-Strategy-Report-24_05_22_WMS.pdf (2024).
Rabin, A. S. et al. Budesonide-Formoterol Metered-Dose Inhaler vs Fluticasone-Salmeterol Dry-Powder Inhaler. JAMA Intern. Med. 185, 1005–1013, https://doi.org/10.1001/jamainternmed.2025.2299 (2025).
Google Scholar
Roggeri, A., Micheletto, C. & Roggeri, D. P. Inhalation errors due to device switch in patients with chronic obstructive pulmonary disease and asthma: critical health and economic issues. Int. J. chronic Obstr. pulmonary Dis. 11, 597–602, https://doi.org/10.2147/copd.S103335 (2016).
Google Scholar
Thomas, M. et al. Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control. BMC pulmonary Med. 9, 1. https://doi.org/10.1186/1471-2466-9-1 (2009).
Google Scholar
NHS England. Blog: Delivering high quality, low carbon respiratory care, https://www.england.nhs.uk/greenernhs/2023/02/blog-delivering-high-quality-low-carbon-respiratory-care/ (2023).
Government of Canada. Draft state of per- and polyfluoroalkyl substances (PFAS) report, https://www.canada.ca/en/environment-climate-change/services/evaluating-existing-substances/draft-state-per-polyfluoroalkyl-substances-report.html (2023).
Chiesi. Environment, https://www.chiesi.com/en/processes/environment/ (2023).
GSK. Our Clim. targets https://www.gsk.com/en-gb/responsibility/environment/climate/ (2023).
AstraZeneca. Trixeo Aerosphere approved UK first inhaled respiratory Med. using. next-generation propellant near-zero Glob. Warm. Potential. https://www.astrazeneca.com/media-centre/press-releases/2025/trixeo-aerosphere-approved-in-the-uk-as-first-inhaled-respiratory-medicine-using-next-generation-propellant-with-near-zero-global-warming-potential.html (2025).
AstraZeneca. Trixeo Aerosphere receives positive EU CHMP opinion as first inhaled medicine using next-generation propellant with near-zero Global Warming Potential, https://www.astrazeneca.com/media-centre/press-releases/2025/trixeo-aerosphere-receives-positive-eu-chmp-opinion-first-inhaled-medicine-using-next-generation-propellant-with-near-zero-global-warming-potential.html (2025).
Bjornsdottir, U. S. et al. Impact of changes to reimbursement of fixed combinations of inhaled corticosteroids and long-acting beta(2) -agonists in obstructive lung diseases: a population-based, observational study. Int. J. Clin. Pract. 68, 812–819, https://doi.org/10.1111/ijcp.12473 (2014).
Google Scholar
Iacobucci, G. GP appointments last less than five minutes for half the world’s population. BMJ. 359, j5172, https://doi.org/10.1136/bmj.j5172 (2017).
Google Scholar
Primary Care Respiratory Society. You Have 10 min for an Asthma Review - Your Time Starts NOW, https://www.pcrs-uk.org/sites/default/files/resource/2023-May-PCRU-10-Minute-Asthma-Review.pdf (2023).
Tseng, K., Lou, S.-J., Diez, C. & Yang, H.-J. Using online nominal group technique to implement knowledge transfer. J. Eng. Educ. 95 https://doi.org/10.1002/j.2168-9830.2006.tb00908.x (2006).
Kulczycki, A. & Shewchuk, R. M. Using Internet-based nominal group technique meetings to identify provider strategies for increasing diaphragm use. J. family Plan. Reprod. health care 34, 227–231, https://doi.org/10.1783/147118908786000550 (2008).
Google Scholar
Lennon, R., Glasper, A., Carpenter, D. Nominal Group Technique: its utilisation to explore the rewards and challenges of becoming a mental health nurse, prior to the introduction of the all graduate nursing curriculum in England., https://www.southampton.ac.uk/assets/centresresearch/documents/wphs/Nominal%20Group%20Technique.pdf.
Harvey, N. & Holmes, C. A. Nominal group technique: an effective method for obtaining group consensus. Int. J. Nurs. Pract. 18, 188–194, https://doi.org/10.1111/j.1440-172X.2012.02017.x (2012).
Google Scholar
Tuffrey-Wijne, I., Bernal, J., Butler, G., Hollins, S. & Curfs, L. Using Nominal Group Technique to investigate the views of people with intellectual disabilities on end-of-life care provision. J. Adv. Nurs. 58, 80–89, https://doi.org/10.1111/j.1365-2648.2007.04227.x (2007).
Google Scholar
Comments (0)